Journal article 1130 views
Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?
,
Diane Kelly
Philosophical Transactions of the Royal Society B: Biological Sciences, Volume: 368, Issue: 1612, Pages: 20120476 - 20120476
Swansea University Authors:
Steven Kelly , Diane Kelly
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1098/rstb.2012.0476
Abstract
The first eukaryote genome revealed three yeast cytochromes P450 (CYPs), hence the subsequent realization that some microbial fungal genomes encode these proteins in 1 per cent or more of all genes (greater than 100) has been surprising. They are unique biocatalysts undertaking a wide array of stere...
| Published in: | Philosophical Transactions of the Royal Society B: Biological Sciences |
|---|---|
| ISSN: | 0962-8436 1471-2970 |
| Published: |
2013
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa14006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
The first eukaryote genome revealed three yeast cytochromes P450 (CYPs), hence the subsequent realization that some microbial fungal genomes encode these proteins in 1 per cent or more of all genes (greater than 100) has been surprising. They are unique biocatalysts undertaking a wide array of stereo- and regio-specific reactions and so hold promise in many applications. Based on ancestral activities that included 14α-demethylation during sterol biosynthesis, it is now seen that CYPs are part of the genes and metabolism of most eukaryotes. In contrast, Archaea and Eubacteria often do not contain CYPs, while those that do are frequently interesting as producers of natural products undertaking their oxidative tailoring. Apart from roles in primary and secondary metabolism, microbial CYPs are actual/potential targets of drugs/agrochemicals and CYP51 in sterol biosynthesis is exhibiting evolution to resistance in the clinic and the field. Other CYP applications include the first industrial biotransformation for corticosteroid production in the 1950s, the diversion into penicillin synthesis in early mutations in fungal strain improvement and bioremediation using bacteria and fungi. The vast untapped resource of orphan CYPs in numerous genomes is being probed and new methods for discovering function and for discovering desired activities are being investigated. |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Issue: |
1612 |
| Start Page: |
20120476 |
| End Page: |
20120476 |